Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Epsilon ketoester reductase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110004119B discloses a thermostable epsilon-ketoester reductase mutant enabling efficient synthesis of (R)-alpha-lipoic acid precursors with reduced catalyst loading and enhanced stability.